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Gender and incidence of dementia in the Framingham
Background
The common forms of dementia, i.e. Alzheimer"sdisease (AD) and vascular dementia, occur more frequently with increasing age, in the presence of vascular risk factors [1] ,limited physical activity [2] andsusceptibility genes (APOE, and more recently 9 other genes: BIN1, CR1, CLU, PICALM, CD33, EPHA1, MS4A4/MS4A6, ABCA7, CD2AP) [3] [4] [5] .
Among other potential risk factors, a link with gender has been particularly contentious.
Indeed, several studies have suggested that women are at higher risk of dementia, especially of the AD type [6] [7] [8] [9] [10] [11] while others have shown no difference [12] [13] [14] . A metaanalysis of eight European population-based studies carried out in the 1990s concluded that the incidence of AD consistently tended to be higher in women [15] whilein another report from the Rotterdam study,a higher incidence of dementia among women was documented only beyond age 90 years [16] .Recently, a study from the Mayo Clinicin
Rochester has shown that prevalence and incidence of "mild cognitive impairment (MCI)" are higher in men than in women [17, 18] , which could be seen as inconsistent with the higher incidence of dementia reported elsewhere among women.
Different hypotheses, which are not all mutually exclusive, have been proposed to explain a possible difference between the sexes in dementia risk.
First, there are several undisputed sex differences in brain development that could play a role in determining structural brain reserve and the susceptibility to cerebral diseases, including dementia. Anatomical differences between brains of women and men include lower gray matter volume andlowercortical thickness in women and, at a macroscopic level,lower brain volume and weight in women [19] [20] [21] [22] [23] .Each of the 4 latteranatomicalcharacteristics has been associated with a higher risk of cognitive decline or dementia [24] and hence could explain the apparent higher incidence of dementia in women.Secondly, molecular mechanisms through either differential exposure to sex hormones or sex specific epigenetic interactions could also play a role [25] [26] [27] .Thirdly, according to the cognitive reserve hypothesis [28] , men have, on average, a higher functional cognitive reserve, measured through a proxy measure such as educational level, so that they can compensate longer for the pathological brain changes of AD (higher clinical resilience), resulting in a delayed clinical expression of dementia in men.
This greater cognitive reserve might arise from the higher education and more cognitively
challenging occupational opportunities open to men in the initial 6-7 decades of the 20 th century.Fourth,differential diagnostic sensitivity according to gender might lead to an earlier diagnosis in women and an apparent lower incidence in men who might die undiagnosed; reflecting for instance a greater sensitivity to spousal cognitive decline among men [29, 30] .
Another potential explanation is that the lower incidence of dementia and AD in men later in lifeis a consequence of differential mortalityin men and women starting as early as mid-life. Under that hypothesis,differential mortality would lead to a selective survival of those men beyond 60 years of age, who areat lower risk of developing dementia. In order to investigate this latter hypothesis, it is essential to rely on large observational studies that have enrolled individuals starting in mid-adult life. Yet, most populationbased studies on dementia started enrollment after the age of 65, i.e. when potentially differential selection between men and women due to premature mortality has already started. A separate panel of FHS physicians reviewed all participant deaths' files to assign dates and causes of death; in a small number of participants in whom cognitive decline had not been detected during their FHS examinations, any suggestion of cognitive impairment at the time of death lead to flagging of participants" records for referral to the dementia group for review following the procedure described above. Cause-specific mortality was assigned by a 3 physician review panel using previously described criteria [35, 36] .
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All participants gave written informed consent and the FHS study protocols and participant consent forms were approved by the Institutional Review Board of Boston University School of Medicine.
Age-specific Cohorts
We separately studied two index groups of participants who survived dementia-free to each of "index" ages, 45 and 65, and described their characteristics (specifically, potential risk factors for dementia of AD and vascular types). Individual participants contributed Person Years (PY) from entry through 2009 until they were diagnosed with dementia, died free of dementia, or were censored at the last date known to be dementiafree. Individual participants could be members of more than one index group.
Characteristics were measured or recorded at the most recent examination attended within 5 years before the index age.
Clinical and laboratory measurements
Participants were categorized according to the presence of ≥1 ApoE ε4 allele. hospital electrocardiographic tracings and records) and cardiovascular disease (defined as coronary heart disease, heart failure, peripheral arterial disease or stroke). Diabetes mellitus was defined as a current fasting blood glucose ≥ 126mg/l, random blood glucose ≥ 200mg/l, or being on anti-diabetic therapy. Participants were categorized as current smokers or non-smokers (including past smokers). Educational achievement was classified here as high school degree or higher.
Statistical analysis
At each index age, for participants who reached the index age dementia-free, we the z-test comparisons. We also described age-group-specific mortality rates (per 1,000
person-years) calculated as the total number of deaths divided by person years at risk, 10 times 1,000. In addition, among cases of dementia matched on age (5-years strata) at diagnosis, we described time from onset of MCI to diagnosis of dementia in women and men.
In order to provide a rough quantitative insight on how early cardiovascular deaths in men could have impacted the difference between men and women in dementia risk after When looking at risk factors common to both dementia and cardiovascular diseases,the proportion of persons with elevated BP (>140/90 mmHg) was lower amongwomen than men at age 45 years (15 versus 25%), but the proportions became similarat55 years, with the prevalence of an elevated BP becoming higher in women beyond age 75 years.Across ages, the frequency of all these conditions increased in both sexes, though coronary heart disease, atrial fibrillation and stroke increased less rapidly in women than men.At age 45, type 2 diabetes was reported in 2% of women and men. Its prevalence then increased over time as expected, though less rapidly in women than men.
Results
Study Population
In summary, at age 45, women did not differ from men in prevalence of an APOE ε4allele and high school diploma.In contrast,they had a lower prevalence than men of hypertension, coronary heart disease, atrial fibrillation and smoking.Overall, prevalence of risk factors for cardiovascular disease increasedwhile the difference between women and men vanished over time.
Incidence of dementia and AD
When starting the observationat index age 45 ( proportion increased from 75% to 81% and from 57% to 69%, respectively. The overallLTR(cumulative risk corrected for competing causes of death, CM-ACI estimated for the remaining lifespan) was 1 in 5 women and 1 in 10 men who reached 45 years of age; LTR of AD was 1 in 5 women and 1 in 10 men.
When starting the observation at index age 65 (Table 3 , Figures 1c and 1d) , the same trends for cumulative incidences and lifetime risk of dementia or ADapplied.
The median time from onset of cognitive impairment to diagnosis of dementia in a subset of 308 men and women matched on age at diagnosis was 1.8 years in women and 2.0 years in men (p=0.083, adjusting for age at diagnosis; interquartile ranges 1.0 to 3.4 and 1.2 to 3.8, respectively).
If we restricted to those with age at diagnosis of dementia later than 70 years (n=150 for women and 150 for men), the median time intervals were 1.8 and 2.1, respectively (diagnosis age-adjusted p=0.131; interquartile ranges 1.0 to 3.4 and 1.2 to 3.8, respectively).
Age-and cause-specific mortality
We explored how a potential selection might have occurred due to differential mortality, especially before the age of 65 (Table 4) . In all age categories, mortality rates were lower in women than men, ranging from 2. (259+73/426+73).Given that in women, CM-UCI was 76.5% (still much higher than 63.9 or 66.5%), it is indeed not feasible that cardiovascular deaths before 65 years explain all the difference for dementia risk between men and women. Nonetheless, our results show that a substantial part of the difference in dementia risk between the genders (20 to 50%) may come from cardiovascular disease before age 65 years.
Discussion
In the FHS (Original and Offspring cohorts), a large population-based cohort with uniformly ascertained outcomes, we show that remaining life-time risk of dementia or AD did not differ between women and men, when starting the observation at mid-life.
The significantly higher cardio-vascular mortality among men compared to women 15 between ages 45 and 65 years may explain a selection of men at the lowest risk for dementia or AD, and account at least partly for the difference between gender. The higher overall life-time risk of dementia or AD in women as compared to men might therefore be interpreted as the combined effect of a longer life expectancy among women, and a selective survival to age 65 of men with the lowest risk of developing dementia.If confirmed in other studies using similar analyses or by more sophisticated modeling, this work has implications for the prevention of dementia and AD.
A large number of population-based studies consistentlyshow that the overall incidence of dementia and AD increase with age, though the difference in risk of dementia among women and men remains controversial.A difference between women and men appears after a certain age as women continue to experience an increased dementia incidence with relatively less steep increases in men. Among the largest studies, EuroDem gathered the individual data of 4 population-based cohort studies in Europe starting from age 65 onwards, including around 530 incident cases of dementia overmore than 28,000 personyears of follow up. This collaboration reported a higher risk for AD among women than men that became apparent after age 75 years, while there was no difference for vascular dementia [15] .Nevertheless, theaverage follow-up period, 2 years, was short, and the studies of Eurodem included a group of women that had been less exposed to high education levels than men. Several other studies with short-term follow-up [8, 14, 40] including an earlier analysisof the FHS data [13] , did not show any difference. In a recent, large study (40,441 person-years and 395 incident dementia cases) starting enrollment as early as 55 years of age, the Rotterdam investigatorsreportedno difference of overall dementia incidence between men and women up to age 90 years, and showed that the incidence of vascular dementia was higher among men than women [16] .We now report data from a second large sample with even earlier enrollment and longer followup.
The observation that dementia prevalence or incidence is always higher in the oldest old individuals, especially among women compared to men, has consistently been reported [41, 42] .Among those late onset dementia cases, a mixed profile including both the degenerative features ofAD and cerebrovascular disease is likely to be dominant [43, 44] .However, one important contribution of our data is to show no clear difference in terms of prevalence or incidence of subtypes among men and women in our cohort at the oldest ages (> age 85 years), consistent with other large, well designed studies [45] .
There might be a synergistic effect of both disease pathologies explaining why lessADpathology is needed to result in clinical expression of the disease in the oldest-old [46, 47] .In the FHS cohort as in others [48, 49] ,notable gender differences exist in the prevalence of cardiovascular risk factors and incidence of cardiovascular deaths. The differential exposure of both genders to cardiovascular risk factors and disease could partly explain why the risk of dementia and especially AD emerges more strongly in women at older ages.
Therefore, our most original contribution is to suggest that beyond survival differences between men and women, a selective survival of men at lower risk of dementia may occur starting as early as mid-life, earlier than in women. Our analysis startsas early as 45 years, when differential mortality due to cardio-vascular causes startsoccurring, is inclusive of those men who die earlier andmight have had, had they survived, the highest risk of dementia, especially vascular or mixed subtypes [49] . More generally, our findings suggest that starting observations at age 65 years for a chronic diseaseof the ageing period mayyield biased comparisonsamong categories when selective survival is explained by risk factors or components that are common to early causes of death and the chronic disease.
In addition, a higher incidence of MCI in men compared to women [18] might be explained by an earlier diagnosis of MCI in men than women as shown by a longer time period between onset of MCI and transition to dementia for men in our dataset. Precise reasons should be further explored, though a simple explanation might be that for cultural reasons men might be diagnosed earlier with MCI than women [50] .
The strengths of our analysis include the use of data from a large population-based cohort, with a long follow-up(around 17 years) starting as early as 45 years before the potential selection due to cardio-vascular deaths begins to occur in men. We believe that selection occurring earlier than age 45 years is unlikely to be of sufficient importance to bias our results. The quality of follow up in Framingham is important as people are seen every two to four years and even those who miss study visits are tracked with home visits, telephone health status updates, record reviews and retrospective status assignment if participants attend a subsequent examination, less than 2% are lost to follow-up with no data on date and cause of death. In addition, the standardized ascertainment of dementia and cause of death should avoid differential information bias among men and women. Therefore, it is unlikely that vascular dementia is misdiagnosed as AD in women. We used an estimation of life-time risk in addition to cumulative incidence, since the latter can only reliably estimate risk over a short period interval.
Among potential limitations, we acknowledge that the FHS is mainly composed of individuals of Caucasian ethnicity and who have achieved high education levels.
Therefore, we caution against extrapolation to other populations unless specific studies report comparable results. Thus our findings need replication on other large databases with standardized ascertainment of dementia and AD in persons of other ethnicities, and in different countries with genetic and cultural differences, and alternative profiles of cause-specific mortality.Further, temporal trends in cause-specific mortality (such as reductions in cardiovascular death among men age 45-65 years) could alter these patterns. Our current statistical modeling methods did not consider confounding factors other than age in the models. Nevertheless, in this cohort, some other major risk factors for AD, i.e level of education and APOE ε4 genotype, were evenly distributed among men and women and did not affect the comparison.
Among the five non-exclusive hypothesis that were raised in the introduction to explain differences in dementia risk between men and women, our data did not allow testing all of them due to lack of information. As far as the cognitive reserve concept is concerned, the original hypothesis is based on the assumptions that firstly a higher cognitive reserve does contribute to delayed onset of dementia or AD and secondly, that men have on average a higher cognitive reserve than women [28] . In the FHS, we used educational status as a proxy for cognitive reserve. Education level could indeed contribute to cognitive reserve either through a direct effect on brain development and function or through better health behaviors or health advantages for those having more wealth and social opportunities. However, an important characteristic of the FHS sample is the high average educational attainment and the absence of difference between men and women.
These two specificities of the FHS sample might contribute to the apparent absence of gender differences in dementia incidence not corrected for competing causes of death.
The link between vascular risk factors and brain structural imaging changes might also be different among gender [51] and require further large studies with available brain imaging data.
This work has potential consequences for future research as it could bring new insight on some recent findings, especially on the link between vascular risk factors and dementia.
Indeed recent reports confirm that the association between vascular risk factors such as smoking, type 2 diabetes, hypertension, obesity [52] [53] [54] and dementia risk depends on whether these factors are measured during mid or late life. Selection bias due to differential mortality rates and differences in the underlying causes of early mortality in men and women that we have demonstrated could explain, at least partly, these discrepancies. This will also be crucial to better structure future prevention strategies [55] . We have been able to only roughly estimate the potential impact of early selection of men due to cardio-vascular deaths (20 to 50% of dementia cases). Therefore, future methodological development will be needed in order to simulate, using more sophisticated counterfactual analyses for example through modeling, how early selection due to death, especially from cardiovascular causes, not only leads to gender differences but could bias the estimation of the dementia risk attributable to various vascular risk 20 factors. Therefore, there is also a need for more prospective studies on the complex patho-physiological interplay between vascular and dementia diseases.
In conclusion, our results based on a large population-based cohort, followed-up as early as mid-life, show that gender differences in the incidence of dementia and AD may not work independently of vascular disease. Screening and reducing cardio-vascular risk factors to decrease the incidence of dementia applies to both genders but as mortality from cardiovascular causes declines, dementia risk might increase further, especially in men. * comparison women vs men  Cumulative incidence not corrected for competing causes of death ‡ Cumulative incidence, corrected for competing causes of death * comparison women vs men  Cumulative incidence not corrected for competing causes of death ‡ Cumulative incidence, corrected for competing causes of death 
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